Molecular characterization and analysis of the biosynthetic gene cluster for the antitumor antibiotic mitomycin C from Streptomyces lavendulae NRRL 2564

This publication has 89 references indexed in Scilit:

• Current Issues in the Enzymology of Mitomycin C Metabolic Activation
  General Pharmacology: The Vascular System, 1998
• 1a-Docosahexaenoyl Mitomycin C: A Novel Inhibitor of Protein Tyrosine Kinase
  Biochemical and Biophysical Research Communications, 1998
• FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome
  Cancer Chemotherapy and Pharmacology, 1998
• The mitomycin bioreductive antitumor agents: Cross-linking and alkylation of DNA as the molecular basis of their activity
  Pharmacology & Therapeutics, 1997
• DNA−DNA Interstrand Cross-Linking by FR66979: Intermediates in the Activation Cascade
  Journal of the American Chemical Society, 1997
• FR900482, a close cousin of mitomycin C that exploits mitosene-based DNA cross-linking
  Chemistry & Biology, 1997
• Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9
  General Pharmacology: The Vascular System, 1996
• Review: Anti-infectives Novel mitomycin derivatives
  Expert Opinion on Therapeutic Patents, 1995
• Microbial mutagenicity and in vitro chromosome aberration induction by FK973, a new antitumor agent
  Mutation Research Letters, 1994
• 3-Amino-5-hydroxybenzoic acid in antibiotic biosynthesis VI. Directed biosynthesis studies with ansamycin antibiotics.
  The Journal of Antibiotics, 1983